Protein-misfolding diseases and chaperone-based therapeutic approaches

被引：287

作者：

Chaudhuri, TK ^{[1
]}

Paul, S ^{[1
]}

机构：

[1] Indian Inst Technol, Dept Biochem Engn & Biotechnol, New Delhi 110016, India

来源：

FEBS JOURNAL | 2006年 / 273卷 / 07期

关键词：

chaperone-based therapeutic approaches; chemical and pharmacological chaperones; molecular chaperones; protein conformational diseases; protein misfolding and aggregation;

D O I：

10.1111/j.1742-4658.2006.05181.x

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A large number of neurodegenerative diseases in humans result from protein misfolding and aggregation. Protein misfolding is believed to be the primary cause of Alzheimer's disease, Parkinson's disease, Huntington's disease, Creutzfeldt-Jakob disease, cystic fibrosis, Gaucher's disease and many other degenerative and neurodegenerative disorders. Cellular molecular chaperones, which are ubiquitous, stress-induced proteins, and newly Found chemical and pharmacological chaperones have been found to be effective in preventing misfolding of different disease-causing proteins, essentially reducing the severity of several neurodegenerative disorders and many other protein-misfolding diseases. In this review, we discuss the probable mechanisms of several protein-misfolding diseases in humans, as well as therapeutic approaches for countering them. The role of molecular, chemical and pharmacological chaperones in suppressing the effect of protein misfolding-induced consequences in humans is explained in detail. Functional aspects of the different types of chaperones suggest their uses as potential therapeutic agents against different types of degenerative diseases, including neurodegenerative disorders.

引用

页码：1331 / 1349

页数：19

共 148 条

[31] Protein misfolding, evolution and disease
Dobson, CM
[J]. TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (09) : 329 - 332
[32] A POINT MUTATION OF THE RHODOPSIN GENE IN ONE FORM OF RETINITIS-PIGMENTOSA
DRYJA, TP
MCGEE, TL
REICHEL, E
HAHN, LB
COWLEY, GS
YANDELL, DW
SANDBERG, MA
BERSON, EL
[J]. NATURE, 1990, 343 (6256) : 364 - 366
[33] DIAGNOSIS OF SPORADIC HUNTINGTONS-DISEASE
DURR, A
DODE, C
HAHN, V
PECHEUX, C
PILLON, B
FEINGOLD, J
KAPLAN, JC
AGID, Y
BRICE, A
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 129 (01) : 51 - 55
[34] Review:: Formation and properties of amyloid-like fibrils derived from α-synuclein and related proteins
El-Agnaf, OMA
Irvine, GB
[J]. JOURNAL OF STRUCTURAL BIOLOGY, 2000, 130 (2-3) : 300 - 309
[35] Danger - misfolding proteins
Ellis, RJ
Pinheiro, TJT
[J]. NATURE, 2002, 416 (6880) : 483 - 484
[36] ENG CM, 1993, AM J HUM GENET, V53, P1186
[37] High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells
Evert, BO
Wüllner, U
Schulz, JB
Weller, M
Groscurth, P
Trottier, Y
Brice, A
Klockgether, T
[J]. HUMAN MOLECULAR GENETICS, 1999, 8 (07) : 1169 - 1176
[38] Accelerated transport and maturation of lysosomal α-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor
Fan, JQ
Ishii, S
Asano, N
Suzuki, Y
[J]. NATURE MEDICINE, 1999, 5 (01) : 112 - 115
[39] Findeis Mark A., 2002, Current Topics in Medicinal Chemistry, V2, P417, DOI 10.2174/1568026024607508
[40] Protein aggregation: folding aggregates, inclusion bodies and amyloid
Fink, AL
[J]. FOLDING & DESIGN, 1998, 3 (01): : R9 - R23

← 1 2 3 4 5 6 7 8 9 10 →